Viveve Medical Statistics
Total Valuation
Viveve Medical has a market cap or net worth of $2,145. The enterprise value is -$23,855.
| Market Cap | 2,145 |
| Enterprise Value | -23,855 |
Important Dates
The last earnings date was Tuesday, August 22, 2023, after market close.
| Earnings Date | Aug 22, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
Viveve Medical has 10.72 million shares outstanding.
| Shares Outstanding | 10.72M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 10.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| Forward PS | 0.00 |
| PB Ratio | 0.00 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 4.97.
| Current Ratio | 0.89 |
| Quick Ratio | 0.62 |
| Debt / Equity | 4.97 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.09 |
Financial Efficiency
Return on equity (ROE) is -2,020.10% and return on invested capital (ROIC) is -299.25%.
| Return on Equity (ROE) | -2,020.10% |
| Return on Assets (ROA) | -196.79% |
| Return on Capital (ROIC) | -299.25% |
| Revenue Per Employee | $145,234 |
| Profits Per Employee | -$508,894 |
| Employee Count | 47 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 3.03 |
Taxes
In the past 12 months, Viveve Medical has paid $1.57 million in taxes.
| Income Tax | 1.57M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.57% in the last 52 weeks. The beta is 0.14, so Viveve Medical's price volatility has been lower than the market average.
| Beta (1Y) | 0.14 |
| 52-Week Price Change | -99.57% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 40.19 |
| Average Volume (30 Days) | 2,862 |
Short Selling Information
The latest short interest is 374,236, so 3.49% of the outstanding shares have been sold short.
| Short Interest | 374,236 |
| Short Previous Month | 213,739 |
| Short % of Shares Out | 3.49% |
| Short % of Float | 3.49% |
| Short Ratio (days to cover) | 4.15 |
Income Statement
In the last 12 months, Viveve Medical had revenue of $6.83 million and -$23.92 million in losses. Loss per share was -$2.29.
| Revenue | 6.83M |
| Gross Profit | 1.12M |
| Operating Income | -21.14M |
| Pretax Income | -22.34M |
| Net Income | -23.92M |
| EBITDA | -20.43M |
| EBIT | -21.23M |
| Loss Per Share | -$2.29 |
Balance Sheet
The company has $5.91 million in cash and $5.88 million in debt, giving a net cash position of $26,000 or $0.00 per share.
| Cash & Cash Equivalents | 5.91M |
| Total Debt | 5.88M |
| Net Cash | 26,000 |
| Net Cash Per Share | $0.00 |
| Equity / Book Value | 1.18M |
| Book Value Per Share | 0.11 |
| Working Capital | -1.23M |
Cash Flow
In the last 12 months, operating cash flow was -$16.23 million and capital expenditures -$595,000, giving a free cash flow of -$16.83 million.
| Operating Cash Flow | -16.23M |
| Capital Expenditures | -595,000 |
| Free Cash Flow | -16.83M |
| FCF Per Share | -$1.58 |
Margins
Gross margin is 16.39%, with operating and profit margins of -309.73% and -350.40%.
| Gross Margin | 16.39% |
| Operating Margin | -309.73% |
| Pretax Margin | -327.34% |
| Profit Margin | -350.40% |
| EBITDA Margin | -299.24% |
| EBIT Margin | -311.05% |
| FCF Margin | -246.51% |
Dividends & Yields
Viveve Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.69% |
| Shareholder Yield | -0.69% |
| Earnings Yield | -1,115,058.28% |
| FCF Yield | -784,475.52% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 2, 2020. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 2, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
Viveve Medical has an Altman Z-Score of -35.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -35.1 |
| Piotroski F-Score | 3 |